Gilead CEO On 2024 drug pipeline: Expect results from around two dozen clinical trials
0
0
08/01/24
Dans
Amérique du Nord / États-Unis
Gilead Sciences CEO Daniel O'Day joins 'Squawk Box' to discuss Gilead's drug pipeline in 2024, the company's HIV treatment, breast cancer drug, and more.
Montre plus
0 commentaires
sort Trier par
